High Tech Pharm (106190) Stock Overview

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem antibiotics worldwide. The company's carbapenem antibiotics are used for the treatment of gram-negative bacterial infections. Its products include sterile imipenem, sterile sodium silicate, sterile imipenem- cilastatin (1: 1), aseptic meropenem, and sterile paniepenem for injection, as well as oral paropenem; and sterile erthapenem, aseptic dori penem, and aseptic via penem for injection. The company was incorporated in 1998 and is based in Daeso-Myeon, South Korea.